CONNECTM TECHNOLOGY SOLUTION (CNTM) Fundamental Analysis & Valuation

NASDAQ:CNTM • US2079441091

Current stock price

0.4401 USD
-0.21 (-32.29%)
At close:
0.259 USD
-0.18 (-41.15%)
After Hours:

This CNTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CNTM Profitability Analysis

1.1 Basic Checks

  • CNTM had negative earnings in the past year.
  • CNTM had a negative operating cash flow in the past year.
CNTM Yearly Net Income VS EBIT VS OCF VS FCFCNTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M

1.2 Ratios

  • CNTM has a Return On Assets (-21.73%) which is comparable to the rest of the industry.
  • CNTM's Return On Equity of -44.61% is in line compared to the rest of the industry. CNTM outperforms 52.08% of its industry peers.
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROIC N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CNTM Yearly ROA, ROE, ROICCNTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -50 -100 -150

1.3 Margins

  • CNTM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CNTM Yearly Profit, Operating, Gross MarginsCNTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CNTM Health Analysis

2.1 Basic Checks

  • CNTM has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, CNTM has a worse debt to assets ratio.
CNTM Yearly Shares OutstandingCNTM Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 500K 1M 1.5M 2M
CNTM Yearly Total Debt VS Total AssetsCNTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • CNTM has an Altman-Z score of -0.79. This is a bad value and indicates that CNTM is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.79, CNTM is in line with its industry, outperforming 42.71% of the companies in the same industry.
  • CNTM has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • CNTM has a Debt to Equity ratio of 0.04. This is in the better half of the industry: CNTM outperforms 73.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z -0.79
ROIC/WACCN/A
WACCN/A
CNTM Yearly LT Debt VS Equity VS FCFCNTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

  • CNTM has a Current Ratio of 0.02. This is a bad value and indicates that CNTM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.02, CNTM is not doing good in the industry: 95.83% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.02 indicates that CNTM may have some problems paying its short term obligations.
  • CNTM has a Quick ratio of 0.02. This is amonst the worse of the industry: CNTM underperforms 95.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
CNTM Yearly Current Assets VS Current LiabilitesCNTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CNTM Growth Analysis

3.1 Past

  • The earnings per share for CNTM have decreased strongly by -92.14% in the last year.
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CNTM Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CNTM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CNTM Price Earnings VS Forward Price EarningsCNTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CNTM Per share dataCNTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CNTM Dividend Analysis

5.1 Amount

  • No dividends for CNTM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CNTM Fundamentals: All Metrics, Ratios and Statistics

CONNECTM TECHNOLOGY SOLUTION

NASDAQ:CNTM (5/7/2025, 8:00:00 PM)

After market: 0.259 -0.18 (-41.15%)

0.4401

-0.21 (-32.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners8.48%
Inst Owner Change-86.49%
Ins Owners3.83%
Ins Owner Change0%
Market Cap15.63M
Revenue(TTM)N/A
Net Income(TTM)-17.41M
AnalystsN/A
Price Target3.32 (654.37%)
Short Float %0.42%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.4
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS1.1
TBVpS1.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -21.73%
ROE -44.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-9.67%
ROA(5y)N/A
ROE(3y)-78.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -0.79
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%133.68%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-294.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-294.55%
OCF growth 3YN/A
OCF growth 5YN/A

CONNECTM TECHNOLOGY SOLUTION / CNTM Fundamental Analysis FAQ

What is the fundamental rating for CNTM stock?

ChartMill assigns a fundamental rating of 1 / 10 to CNTM.


Can you provide the valuation status for CONNECTM TECHNOLOGY SOLUTION?

ChartMill assigns a valuation rating of 0 / 10 to CONNECTM TECHNOLOGY SOLUTION (CNTM). This can be considered as Overvalued.


What is the profitability of CNTM stock?

CONNECTM TECHNOLOGY SOLUTION (CNTM) has a profitability rating of 1 / 10.